BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6529603)

  • 1. Further studies on the histamine metabolism in the M-2 adenocarcinoma.
    Scolnick AJ; Rubio MC; Colombo LL; Comolli RR; Caro RA
    Biomed Pharmacother; 1984; 38(9-10):465-7. PubMed ID: 6529603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abnormal histamine metabolism in a transplantable syngeneic spontaneous murine mammary adenocarcinoma.
    Scolnik AJ; Rubio MC; Comolli RR; Colombo LL; Caro RA
    Biomedicine; 1981 Jul; 35(3):84-7. PubMed ID: 7272425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosynthesis and subcellular localization of histamine in H-110 lymphoma.
    Scolnik AJ; Rubio MC; Caro RA; Ciscato VA
    Biomedicine; 1978 Oct; 28(5):274-7. PubMed ID: 743553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mammary histidine decarboxylase vulnerability to enzyme antisense oligonucleotides: histamine and polyamine systems cross-talk.
    Wagner W; Fogel WA
    Amino Acids; 2004 Jul; 26(4):311-6. PubMed ID: 15290335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Involvement of histamine in growth of mouse and rat tumors: antitumoral properties of monofluoromethylhistidine, an enzyme-activated irreversible inhibitor of histidine decarboxylase.
    Bartholeyns J; Bouclier M
    Cancer Res; 1984 Feb; 44(2):639-45. PubMed ID: 6692368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of cimetidine on intratumoral cytokine expression in an experimental tumor.
    Takahashi K; Tanaka S; Ichikawa A
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1113-9. PubMed ID: 11243850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-11-induced reduction of C/EBP transcription factor binding may contribute to the IL-12 downregulation in tumor-bearing mice.
    Torroella-Kouri M; Keith JC; Ivanova M; Lopez DM
    Int J Oncol; 2003 Feb; 22(2):439-48. PubMed ID: 12527946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased histamine content and metabolism in mammary cancer tissue from C3H mice.
    Kierska D; Szymańska H; Maslinski C
    Agents Actions; 1992 Nov; 37(3-4):227-31. PubMed ID: 1295372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine concentration and metabolism in mouse mammary gland during the estrous cycle.
    Kierska D; Fogel WA; Maslinski C
    Inflamm Res; 1997 Mar; 46 Suppl 1():S63-4. PubMed ID: 9098767
    [No Abstract]   [Full Text] [Related]  

  • 10. Distribution of furamidine analogues in tumor cells: targeting of the nucleus or mitochondria depending on the amidine substitution.
    Lansiaux A; Tanious F; Mishal Z; Dassonneville L; Kumar A; Stephens CE; Hu Q; Wilson WD; Boykin DW; Bailly C
    Cancer Res; 2002 Dec; 62(24):7219-29. PubMed ID: 12499262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of 3H-histamine interaction with lymphocytes: receptor binding or uptake?
    Wang Y; Kristensen F; Joncourt F; Slauson DO; De Weck AL
    Clin Exp Immunol; 1983 Nov; 54(2):501-8. PubMed ID: 6652970
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of DNA synthesis by 3H-thymidine incorporation into needle aspirates from human tumors.
    Nordenskjöld B; Zetterberg A; Löwhagen T
    Acta Cytol; 1974; 18(3):215-21. PubMed ID: 4525221
    [No Abstract]   [Full Text] [Related]  

  • 13. Will the best model of breast cancer please come forward?
    Hilf R
    Natl Cancer Inst Monogr; 1971 Dec; 34():43-54. PubMed ID: 4335260
    [No Abstract]   [Full Text] [Related]  

  • 14. Increase of histidine decarboxylase activity in mice hypothalamus after intracerebroventricular administration of lipopolysaccharide.
    Niimi M; Mochizuki T; Cacabelos R; Yamatodani A
    Methods Find Exp Clin Pharmacol; 1993 Oct; 15(8):509-14. PubMed ID: 8309315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel method for estimating the labeling index in clinical specimens with the use of immunoperoxidase-labeled.
    Liebskind D; Hsu KC; Elequin F; Mendez L; Ghossein N; Janis M; Bases R
    Cancer Res; 1977 Jan; 37(1):323-6. PubMed ID: 318608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histamine in C3H/W mice carrying spontaneous tumors of the mammary gland.
    Maslinski C; Kierska D
    Agents Actions; 1991 May; 33(1-2):192-4. PubMed ID: 1897438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucocorticoids coordinately disrupt a transforming growth factor alpha autocrine loop and suppress the growth of 13762NF-derived Con8 rat mammary adenocarcinoma cells.
    Alexander DB; Goya L; Webster MK; Haraguchi T; Firestone GL
    Cancer Res; 1993 Apr; 53(8):1808-15. PubMed ID: 8467499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of tumor radioactivity after the administration of either 125I- or 3H-labeled 5-iodo-2'-deoxyuridine.
    Dethlefsen LA
    Cancer Res; 1969 Sep; 29(9):1717-20. PubMed ID: 5822480
    [No Abstract]   [Full Text] [Related]  

  • 19. Histamine production via mast cell-independent induction of histidine decarboxylase in response to lipopolysaccharide and interleukin-1.
    Wu X; Yoshida A; Sasano T; Iwakura Y; Endo Y
    Int Immunopharmacol; 2004 Apr; 4(4):513-20. PubMed ID: 15099528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced expression of angiotensin II receptor subtypes and angiotensin converting enzyme in medroxyprogesterone-induced mouse mammary adenocarcinomas.
    Guerra FK; Ciuffo GM; Elizalde PV; Charreau EH; Saavedra JM
    Biochem Biophys Res Commun; 1993 May; 193(1):93-9. PubMed ID: 8389152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.